Meet The Team


Jenna Baker, PhD

Co-Founder & CEO

A broadly trained scientist with research across multiple disciplines, Jenna brings more than 20 years of life science experience in the academic, private, and government sectors to Basin Genomics.  By combining her background in computational and functional genomics with her leadership experience, she is helping Basin Genomics translate clinically relevant genomic signatures into advances in personalized clinical care.


Anne Shiflett, MBA, CPA

Chief Business Officer

As the Chief Business Officer for Basin Genomics, Anne brings over 30 years of managerial, financial, and accounting experience to Basin Genomics, most recently as Vice President, Finance and Administration at Catalent Pharma Solutions (formerly Paragon Bioservices, Inc.) where she was instrumental in the sale of Paragon to Catalent in May 2019. She has expertise in leading the start-up and rapid growth of new and emerging companies. 


Joe Sullivan


Joe brings over 25 years of global healthcare experience in oncology, infectious disease, and respiratory therapeutic areas. He led the introduction for Merck of the first HPV vaccine, Gardasil, and was responsible for the formation of numerous global research, commercial, & manufacturing partnerships. He is recognized for his many successes commercializing technologies and building new product markets.


Anna Giuliano, PhD

HPV Scientific Advisor

Dr. Giuliano is the Founding Director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center. Her work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.

David Esposito.jpeg

David Esposito

Senior Strategy Advisor

David is a seasoned healthcare CEO and Combat Veteran with over 20 years of experience commercializing diagnostics. He has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers.  He was the CEO at Armune BioScience, which sold to Exact Sciences [EXAS] in Dec. 2017, as well as the US President at Phadia US/AB, which sold to Thermo Fisher Scientific [TMO] Sept. 2011). 

Lynn Barclay

Policy Advisor

Lynn has been the President and CEO of the American Sexual Health Association and the National Cervical Cancer Coalition since 2006, advocating for HPV 

vaccination and testing.  She works closely with colleague organizations, from the American Sexual Transmitted Diseases Association, the National Coalition of STD Directors, and the Centers for Disease Control and Prevention. 


Anna-Barbara Moscicki, MD

Clinician & HPV Researcher

Anna-Barbara is a clinician and researcher at UCLA, with a specific focus on HPV. She is the Past President of American Society for Colposcopy and Cervical Pathology and serves on committees for the WHO, NIH, and ACS. She was the PI of one of the longest running HPV studies (+25 years). Her work was highly influential in forming the new cervical cancer screening guidelines in the US.

Jason Mendelsohn

Patient Advocate

Jason is a survivor of stage 4 HPV oral cancer. Having won this battle in 2015, he is on a mission to stop anyone else from having to go through the same experiences he endured.  He is the founder of Superman HPV, dedicated to  providing information on HPV-related cancers and resources for support. Jason is also the Co-Founder & President of the Ashar Group.